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Abstract: In this work, stents were produced from natural ori-
gin polysaccharides. Alginate, gellan gum, and a blend of
these with gelatin were used to produce hollow tube (stents)
following a combination of templated gelation and critical
point carbon dioxide drying. Morphological analysis of the
surface of the stents was carried out by scanning electron
microscopy. Indwelling time, encrustation, and stability of
the stents in artificial urine solution was carried out up to 60
days of immersion. In vitro studies carried out with simulated
urine demonstrated that the tubes present a high fluid uptake
ability, about 1000%. Despite this, the materials are able to
maintain their shape and do not present an extensive swel-
ling behavior. The bioresorption profile was observed to be
highly dependent on the composition of the stent and it can
be tuned. Complete dissolution of the materials may occur
between 14 and 60 days. Additionally, no encrustation was
observed within the tested timeframe. The ability to resist
bacterial adherence was evaluated with Gram-positive Staph-
ylococcus aureus and two Gram-negatives Escherichia coli
DH5 alpha and Klebsiella oxytoca. For K. oxytoca, no differ-
ences were observed in comparison with a commercial
stent (BiosoftV
R
duo, Porges), although, for S. aureus all
tested compositions had a higher inhibition of bacterial
adhesion compared to the commercial stents. In case of
E. coli, the addition of gelatin to the formulations reduced
the bacterial adhesion in a highly significant manner com-
pared to the commercial stents. The stents produced by the
developed technology fulfill the requirements for ureteral
stents and will contribute in the development of biocom-
patible and bioresorbable urinary stents. VC 2014 Wiley Periodi-
cals, Inc. J Biomed Mater Res Part B: Appl Biomater 00B: 000–000,
2014.
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INTRODUCTION
Stents have a wide range of applications in urology. Stent-
based strategies are usually applied in the ureter to ensure its
patency, which may be compromised, for example, by a kid-
ney stone. This method is sometimes used as a temporary
measure to prevent damage to a blocked kidney until a proce-
dure to remove the stone is performed. Indwelling times for
these cases are typically from 15 up to 60 days. In the case of
tumors, stents are indicated to hold open ureters, which have
been compressed in the area of the tumor or by the tumor
itself. Stents used to guarantee drainage of urine ﬂow through
the ureter should have, in these cases, indwelling times of 12
months or longer.1 The main complications with ureteral
stents are dislocation, infection, and blockage by encrusta-
tion.2,3 Currently, nearly 100% of the people who have an
urological stent are likely to develop a bacterial infection
within 30 days, which increases morbidity threefold.4 Diffe-
rent types of temporary and permanent stents have been
introduced into urological practice to relieve obstructions.5,6
In terms of ureteral stents composition materials, the gold
standard are polymeric compounds from different families,
including silicone, polyurethane Siliteck, among others.7 How-
ever in some cases, polymeric stents demonstrate certain li-
mits in their ability to resist external compression forces and
in certain cases metallic materials have been introduced as
they are more resistant stents.8
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Despite the fact that stent designs has improved over
the years, they present one major key disadvantage, which
is the fact that they have to be removed by second interven-
tion. Avoiding a secondary procedure to remove the ureteral
stents is highly desirable. The development of biodegradable
ureteral stents has been pursued previously. However,
regardless of early positive results with various models,9–12
these attempts were abandoned due to biocompatibility
issues in porcine ureters13 or because they degraded in
inhomogeneous, premature, or delayed fashion.14,15 Hydro-
gels can be applied as a coating surface modiﬁcation to ure-
teral stents. Hydrogel-coated stents have advantages such as
improved material biocompatibility, hydrophilization, and
lubrication.16,17 Hydrogels are polymeric networks which
may present relevant mechanical properties, appropriate
degradation rates, reduced bioﬁlm formation,18–20 and con-
stitute per se, an interesting alternative to conventional uro-
logical stents. An ideal stent for the lower urinary tract
would provide adequate support to the duct wall, like the
urethra or ureter, keeping the lumen open during and after
the healing process, and then biodegrade totally from the
body.2,21 The material needs to fulﬁll the biocompatibility
demands according to the guidelines of tissue biocompati-
bility analysis and risk assessment of new medical devices.
The rigidity of the material has to be suited to the place of
application; the degradation products should be biocompati-
ble; and the rate of degradation should be adequate to allow
healing. The devices also need to be easily sterilized without
change in the morphological and mechanical properties.22 It
has been reported in the literature that the coating of poly-
meric stents with hydrogels is able to improve the proper-
ties of the stent, like anti-bacterial properties2,16; however,
to our knowledge, simple hydrogel stents have not been
reported. The concerns regarding existing stents are the
motivation to design new bioresorbable urological stent sys-
tems based on natural polymers, which present inherent
biocompatibility, anti-bacterial properties, and can be tailor-
made into a custom suitable stent for a particular patient.
The characteristics of an ideal temporary stent include easy
placement under local anesthesia, minimal local side-effects,
such as tissue hyperplasia or encrustation, and a low risk of
migration. The device must also be easily removable or,
preferably, bioresorbable to reduce the necessity of further
surgical intervention.
The compositions herein tested were based on polysac-
charides of natural-origin, in particular alginate, gellan gum,
and their blends with gelatin. These polysaccharides have
advantages over other polymers currently used to produce
stents. As a main advantage, they are bioresorbable and its
use does not require a second surgery to remove the stent.
The mechanical properties of these materials suggest that
they can be used for this purpose, since they present elas-
ticity and, at the same time, they allow urine ﬂow through
the obstructed region. With the properties of the proposed
stents it is expected a reduction of the pain experienced by
patients when compared to conventional stents as the stents
prepared are softer. Furthermore, it is expected that the
stent implantation is easier, due to the lubricity properties
of the hydrogels, being hereafter more comfortable for the
patient. Conventional stents coated with hydrogels have
been reported to provide an improvement to the resistance
to bacterial adhesion, and bioﬁlm formation.23 Furthermore,
the developed stents also exhibited adequate resistance to
encrustation. The development of these stents with the
above-mentioned properties anti-bacterial, bioresorbable,
and appropriate geometry will be pursued in this work.
MATERIAL AND METHODS
Materials
Gelzan CM (gellan gum), alginic acid sodium salt, gelatin,
urea, potassium chloride, calcium chloride, and ethanol
were purchased from Sigma-Aldrich (Germany). Potassium
dihydrogen ortho-phosphate (99.5%) and magnesium chlo-
ride hexahydrate (99%) were obtained from Riedel-de Ha€en
(Germany). Carbon dioxide (99.998 mol %) was supplied by
Air Liquide (Portugal). All reagents were used as received.
Preparation of polymer solutions
Polymers were dissolved in hot distilled water (90C) at dif-
ferent concentrations, and stirred for 1 h. The polymeric
solution was injected in a template of appropriate geometry
and immersed at room temperature in a stirred CaCl2 or
KCl crosslinking solution. This step allows the geliﬁcation of
the polymer. In Table I, the concentrations of polymers and
crosslinking agents used to prepare the aerogel-based stents
are summarized.
Sample drying
Supercritical ﬂuid drying with CO2 is an alternative process
to the conventional drying techniques, which preserves the
properties of the wet gel in the dry form. The stents were
dried in a high-pressure vessel with carbon dioxide at 40C
and 100 bar for 2 h, in a continuous mode, with a CO2 ﬂow
rate of 15 g/min. The conditions were chosen in order to
ensure complete miscibility between the CO2 and ethanol.
Different processing times were tested and 2 h was estab-
lished as the necessary drying timeframe.
Characterization
Scanning electron microscopy. The morphology of the
stents was analyzed on a Leica Cambridge S360 scanning
electron microscopy (SEM). The samples were ﬁxed with
mutual conductive adhesive tape on aluminum stubs and
covered with gold/palladium using a sputter coater.
TABLE I. Polymer and Crosslinking Agent Concentrations
Used to Prepare the Stents
Polymers
Polymer
Conc.
(wt %)
Crosslinking
Agent
Crosslinking
Agent
Conc. (M)
Alginate 6 CaCl2 0.24
Alginate:gelatin (60:40)
Gellan gum 4
Gellan gum:gelatin (60:40)
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After immersion in artiﬁcial urine solution (AUS) the
inner section of the stents was also analyzed to monitor the
deposition of crystals.
Artiﬁcial urine uptake. AUS was prepared as described by
Khandwekar and Doble,23 with the composition presented
in Table II.
The AUS uptake capability of the samples was meas-
ured for a period up to 60 days by their immersion in
AUS. Pre-weighted stents were immersed in 10 mL of AUS
and placed in a water bath at 37C, 60 rpm for 1, 7, 14,
28, and 60 days. All the experiments were executed in trip-
licate. At the predetermined time periods, the samples
were weighted in order to determine the uptake capability
of the stents. AUS uptake was determined using the follow-
ing equation:
% AUS uptake5 ww2wfð Þ=wf 3100 (1)
where ww is the weight of the wet sample and wf is the
ﬁnal weight (dried after immersion). The presented data is
the average of at least three measurements.
Swelling. Images of dry and wet samples were taken using
a Stereo Microscope1 Lamp (Schott KL 200), stemi 1000
model (ZEISS), with a magniﬁcation 32 and the swelling of
the matrix was evaluated by the measurement of the thick-
ness of the wall using Image J software. The presented
results are an average of at least ﬁve measurements (6SD)
of each sample.
Indwelling time. The indwelling time was measured as
function of the weight loss of the samples. Samples
immersed in AUS were dried and weighted to determine the
weight loss, which was calculated according to the following
equation:
% weight loss5 wf2wið Þ=wi3100 (2)
where wf is the ﬁnal weight of the sample (dried after
immersion) and wi is the initial weight of the sample. Each
formulation was tested in triplicate.
Tensile mechanical analysis
Tensile mechanical analysis of the materials produced (A—
alginate; AG—alginate:gelatine; GG—gellan gum; GGG—gel-
lan gum:gelatine) was measured using an INSTRON 5540
(Instron Int. Ltd, High Wycombe, UK) universal testing
machine with a load cell of 1 kN. The samples were
hydrated before testing in simulated urine for 30 min. The
dimensions of the specimens used were 5 mm of length,
2 mm width, and 0.5 mm of thickness. The load was placed
midway between the supports with a span (L) of 3 mm.
The crosshead speed was 1:5 mm min21. For each condition
the specimens were loaded until core break. The results
presented are the average of at least three specimens and
the results are presented as the average6 standard
deviation.
Encrustation development
The evaluation of the deposition of crystals on the surface
of stents was performed following the procedure described
by Tunney et al.24 Samples of the different stents were
immersed in AUS for predetermined time periods. They
were removed and rinsed gently with distilled water to
remove any salts (which might be only deposited on the
surface). Energy dispersive X-ray spectroscopy (EDS) was
performed together with SEM in a Link Exl-II spectroscope
(Oxford Instruments, United Kingdom) for elemental analy-
sis, with an energy of 15.0 keV. Samples were ﬁxed as
described for SEM analysis and carbon coated using high
vacuum carbon deposition.
Bacterial adhesion studies
Bacterial adhesion studies were performed according to
Khandwekar and Doble.23 A quantitative short-term adhe-
sion (4 h) study was performed with Staphylococcus aureus
(NCIM 5021), a Gram-positive organism, and two Gram-
negative organisms Escherichia coli DH5 alpha and Klebsiella
oxytoca; 100 mL of lysogeny broth (LB) medium (1% bacto
tryptone, 5% bacto yeast extract, and 1% sodium chloride)
was inoculated with a single colony of bacteria from a LB
agar stock plate. Cells were grown at 37C and 200 rpm,
overnight. Cells were then split between two falcon tubes,
centrifuged at 3500 rpm for 20 min and resuspended in
phosphate buffered saline (PBS). Cell suspension was
washed twice with PBS and resuspended at a concentration
of 1 3 108 cells/mL. Three tubes (3 mm length) of each for-
mulation were placed in a 24-well plate and were incubated
with 1 mL of the cell suspension for 4 h at 37C with shak-
ing. The bacterial cells were eluted from the surfaces into
2 mL sterile PBS. The procedure involved 4 min sonication
followed by 1 min mild vortexing (repeated three times)
using an ultrasonic cleaner (Bandelin Sonorex Digitec) with
an ultrasonic frequency of 35 kHz. A known volume of the
sample was inoculated into LB agar and incubated at 37C
for 24 h. The colony forming units (CFUs) were counted
indicating the total number of bacteria retained on the
surface.
Cytotoxicity and cell adhesion studies
Cell culture. An immortalized mouse lung ﬁbroblasts cell
line (L929) purchased from the European Collection of Cell
Cultures, was maintained in basal culture medium DMEM
(Dulbecco’s modiﬁed Eagle’s medium; Sigma–Aldrich,
TABLE II. Composition of the Artificial Urine Solution (AUS)
Component % wt/vol
Solution A Potassium dihydrogen ortho-phosphate 0.76
Magnesium chloride hexahydrate 0.36
Urea 1.60
Solution B Calcium chloride hexahydratate 0.53
Chicken ovalbumin 0.2
Urease 0.125
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Germany), 10% FBS (heat-inactivated fetal bovine serum,
Biochrom AG, Germany), and 1% antibiotic-antimycotic
(Gibco, UK). Cells were cultured in a humidiﬁed incubator
at 37C in a 5% CO2 atmosphere.
Indirect cytotoxicity studies. The cytotoxicity of the stents
developed was assessed using an immortalized mouse lung
ﬁbroblasts cell line (L929) purchased from the European
Collection of Cell Cultures. The effect of the leachables
released from the stents (during 24 h) on the cellular
metabolism was performed using a standard MTS (Cell Titer
96V
R
Aqueous Solution Cell Proliferation Assay, Promega,
USA) viability test, in accordance with ISO/EN 10993 guide-
lines. A latex rubber extract was used as positive control for
cell death; the extracts from a commercial stent (BiosoftV
R
duo, Porges) was used as a reference material; while cell
culture medium was used as negative control representing
the ideal situation for cell proliferation. Cell viability was
evaluated by the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy-
methoxyphenyl)-2-(4-sulphofenyl)-2H-tetrazolium (MTS) assay
after 72 h. This assay is based on the bioreduction of a tetra-
zolium compound MTS into a water-soluble purple formazan
product. This was quantiﬁed by UV-spectroscopy, reading the
formazan absorbance at 490 nm in a microplate reader (Syn-
ergy HT, Bio-Tek Instruments, USA). Each sample formulation
and control were tested using 12 replicates.
Direct contact studies. Conﬂuent L929 cells were harvested
and seeded in the stents as follows: stents were distributed
in a 48-well cell culture plate (BD Biosciences, USA); sam-
ples were initially immersed in sterile PBS in order to swell;
afterwards, PBS was removed and a drop (20 mL) of a cell
suspension with a concentration of 1 3 105 cells/mL was
added to each material. Cell seeding on the commercial
stent was also carried out as control. The cells-stents con-
structs were statically cultured for 1, 3, and 7 days under
the culture conditions previously described. Cell adhesion to
the surface of the materials was determined after the pre-
determined culture times by the MTS assay described above.
The cell-stents were transferred to a new culture plate in
order to evaluate the presence of viable cells only on the
surface of the developed materials. Optical density (wave-
length of 490 nm) was determined for each time point and
compared to polystyrene tissue culture plate, used as a pos-
itive control. All cytotoxicity screening tests were performed
using three replicates.
Statistical analysis
Statistical analysis was performed to compare the results
obtained using GraphPad Prism 5. Shapiro–Wilk test was
used to verify the normality of the data obtained. Normally
distributed data were analyzed by t-student test comparing
each tested stent with the commercial stent, in case of bac-
terial adhesion study. Non-parametric tests were performed
in the case of cytotoxicity and cell adhesion samples with
deviation of the data from the normal distribution. Mann–
Whitney test was performed to pairs of independent sam-
ples in order to compare the medians of the results. Statisti-
cal signiﬁcant differences were considered when p< 0.05.
RESULTS
Stents from natural origin polymers
Stents were prepared following the processing steps repre-
sented in Figure 1. The tube is formed from an initial aque-
ous solution of biopolymer from which gelation is induced.
Gelation in the case of alginate tubes was promoted by ionic
crosslinking with a CaCl2 solution. In the case of gellan gum
lowering the solution temperature induces gelation, which
is a physical crosslinking method. In order to confer stabil-
ity to the tubes, and avoid their premature dissolution in
aqueous solutions, gellan gum was also ionically crosslinked
with KCl and CaCl2 solution, respectively. The hydrogels
were, then, dehydrated and subject to a solvent exchange
step where an alcohol gel was formed. In this process, etha-
nol replaced water and the material was further dried using
supercritical carbon dioxide.25
FIGURE 1. Methodology used to generate the different stents. [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
4 BARROS ET AL. BIORESORBABLE UROLOGICAL STENTS FROM NATURAL ORIGIN POLYMERS
Scanning electron microscopy. Figure 2 presents a SEM
image of the hollow tubes after drying. This procedure
allowed the preparation of a stent with a diameter of 1 mm
in dry sate, which did not show any dependence on: the
type of biopolymer used; on the polymer concentration in
solution; nor on the type of crosslinking.
Characterization
Artiﬁcial urine uptake and indwelling time. The micro-
graphs in Figure 3 show that, upon hydration, the inner
diameter of the stents increased from 1.0 (SD 60.3) to 1.8
(SD 60.2) mm. These stents are able to maintain their
shape and integrity upon immersion in simulated body ﬂu-
ids, as observed for periods up to 60 days of immersion.
In clinical practice, the indwelling time is deﬁned as the
time ranging from the implantation of the stent until its
removal, which is dependent on the clinical treatment
deﬁned for each patient.26 Therefore, it would be desirable
to tune the degradation of the stents to accommodate the
devices for a given indwelling time. The weight loss, meas-
ured as the percentage of mass lost when immersed in AUS
for a predetermined time period, was assessed for the dif-
ferent formulations of stents developed (Figure 4).
Using the processing methodology, herein detailed, it is
possible to tune the degradation rate of the stents by selec-
ting the materials used to produce them. Furthermore, the
extent of crosslinking can confer different properties to the
stents. In vitro performance demonstrates that the indwelling
time of the proposed materials in solution can be tuned from
14 up to 60 days. The stents based on alginate were the ones
that presented a faster dissolution and after 21 days of
immersion the materials was completely dissolved in the
solution.
Mechanical tests. The mechanical properties of the stents
prepared were evaluated in tensile mode. Table III presents
the results obtained for the different formulations tested.
The results presented were determined in the wet state, in
AUS, mimicking the real application conditions.
Encrustation development. The deposition of salts was
evaluated by SEM and EDS. Figure 5 presents a micrograph
FIGURE 2. SEM micrographs of the gellan gum: gelatin stent (60:40%
wt/wt).
FIGURE 3. AUS uptake by the developed stents (A—alginate; AG—alginate:gelatine, GG—gellan gum; GGG—gellan gum:gelatine) during a time-
frame of 60 days, and swelling images using a magnifying lens (23), showing a change in the internal diameter from 1.0 mm to 1.8 mm. Bio-
softVR duo, Porges Stent was used as a control. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 4. Weight loss of the developed stents (A—alginate; AG—algi-
nate:gelatine, GG—gellan gum; GGG—gellan gum:gelatine) during a
time frame of 60 days (indwelling time). BiosoftV
R
duo, Porges Stent
was used as a control.
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of the inner surface of the stents after immersion and the
corresponding EDS spectra. The results point out that no
encrustation was detected in any of the materials herein
proposed.
Bacterial adhesion studies. Bacterial adhesion is a serious
concern related with the formation of bioﬁlm on the surface
of the stents. The ability of bacteria to adhere and prolifer-
ate on the surface of the materials was studied for three dif-
ferent bacteria: S. aureus (Gram-positive); and E. coli DH5
alpha and K. oxytoca (Gram-negative) and the obtained
results are presented in Figure 6. Statistical analysis indi-
cated a signiﬁcant reduction in adhesion of both S. aureus
and E. coli DH5 alpha to alginate gelatin and gellan
gum1 gelatin stents in comparison with the commercial
stent (312, 341, and 32, respectively). The extent of
reduction was found to be greater for S. aureus when com-
pared to E. coli DH5 alpha (Figure 6). Relative to K. oxytoca,
no alteration on the adhesion proﬁle was observed for any
of the tested stents. Moreover, it is relevant to notice that
the stents prepared with gelatin present signiﬁcantly lower
bacterial adhesion, suggesting that these materials may be
the ones that have higher potential in the development of
bioresorbable ureteral stents.
Cytotoxicity and cell adhesion studies. The cytotoxicity of
the six developed stents was evaluated in accordance with
the protocol described in ISO/EN 10,993.27 As a control, the
commercial stent BiosoftV
R
duo (Porges) was used. The via-
bility of the cells cultured in a tissue culture plate, in the
presence of the stents, was determined as a function of the
cells cultured in Dulbecco’s modiﬁed Eagle medium (DMEM)
culture medium. Figure 7(a) presents the cell viability after
72 h in contact with the material. The obtained results were
compared to cell growth on tissue culture plate.
No signiﬁcant differences were observed for the cell via-
bility in the presence of the developed stents in comparison
with the one obtained for the commercial stent, which was
used as a negative control.
TABLE III. Mechanical Properties of the Stents Prepared
Maximum Load
(N)
Maximum Tensile
Strain (%)
Young Modulus
(Mpa)
A 0.736 0.01 11.756 0.60 18.176 1.04
AG 0.566 0.02 15.846 0.58 13.196 0.82
GG 1.116 0.04 20.936 0.78 28.256 1.47
GGG 0.966 0.04 29.686 0.54 26.626 1.24
FIGURE 5. SEM micrographs and EDS spectra of the surface of the stents prepared with the different polymers before and after immersion in
AUS—last time point corresponds to 14 days for alginate-based stents and 60 days for gellan gum-based ones. BiosoftV
R
duo, Porges Stent was
used as a control.
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In this context, cells were seeded directly on the surface
of the stents and the adhesion was studied after 1 and 3
days of culture by MTS viability assay. Cells seeded on tis-
sue culture plate were used as control [Figure 7(b)].
MTS analysis revealed that no cells are present in the
surface of the materials after 1 or 3 day of culture. As it can
be observed from Figure 7(b), the developed stents present
a behavior similar to the commercial stent. Clear differences
between cell growth on the tissue plate and on the stent
surfaces are observed. This observation would be expected
due to the hydrophilic nature of the tested biopolymers.
Nonetheless, there are reports in the literature which indi-
cate that cells are able to adhere and grow on the tested
substrates.28–30
DISCUSSION
An urological stent is deﬁned as a thin tube, which is
inserted in the ureter to prevent or treat the obstruction of
urine ﬂow from the kidney to bladder. Bioresorbable
natural-origin hydrogels present characteristics, which con-
fer them several advantages, such as, biocompatibility, inter-
face lubricity, as well as resistance to bioﬁlm formation and
encrustation.31 The main objective of the present research
work is the preparation of hollow tubes from natural origin
polymers, namely, alginate, gellan gum, and their blends
with gelatin and to evaluate suitability, to be used as ure-
teral stents. Different blends of natural polysaccharides with
gelatin have been reported in the literature.31–33 The vari-
ability of gelatin chemical composition confers this biopoly-
mer different molecular weight and polydispersity, which
per se have shown to substantially inﬂuence mechanical and
thermal properties of physical gels.34 The combination of
polysaccharides with gelatin is expected, to induce changes
in the water uptake, degradation proﬁle, and the in vitro
biological performance of the ureteral stents. These changes
were particularly noticeable in the bacteria adhesion stud-
ies, which have demonstrated that the presence of gelatin in
the blend lower the number of adhered bacteria.
The technology developed for the preparation of the hol-
low tubes, although not new, has not been applied for the
purpose reported in this work (Figure 1). One of the main
advantages of the process is the use of supercritical carbon
dioxide as drying agent. This has demonstrated several
advantages over conventional drying methods, such as
freeze-drying or vacuum drying.28 Both freeze-drying and
vacuum drying involve a phase transition, solid–vapor and
liquid–vapor, respectively. The phase transition is responsi-
ble for an interfacial tension, which results in the shrinkage
and deformation of the produced matrices. On another
hand, supercritical drying with carbon dioxide is a process
which the matrices do not undergo any phase transition
and therefore the integrity of the structures is not compro-
mised.33 In the supercritical drying process, carbon dioxide
replaces the solvent molecules within the polymeric matrix
and removes the organic solvent due to their miscibility at
the drying conditions. The production of hollow tubes by
the proposed technology (Figure 2) foresee its versatility as
the change of the template allows the preparation of materi-
als with different shapes, making it possible to control the
thickness of the wall, the inner diameter, and the mechani-
cal properties. It is also possible to create a material with
different layers by dipping the template, sequentially, in dif-
ferent polymeric solutions. Such bottom up approach to
obtain multilayered hydrogels was validated before on
spherical objects.25
FIGURE 6. Bacterial adhesion on the stents incubated with approxi-
mately 1 3 108 (a) S. aureus bacterias (Gram1), (b) E. coli DH5 alpha
(Gram2), and (c) K. oxytoca (Gram2) for 4 h. Values indicate mean6
standard deviation from a single experiment performed in triplicate,
which was representative of three independent experiments. Fold
adhesion reduction between each tested stents and the commercial
stent is indicated on top of each bar. Significance of the values
between each tested stents and the commercial stent was determined
by the t-student test (***p< 0.001). A—alginate; AG—alginate:gela-
tine, GG—gellan gum; GGG—gellan gum:gelatine.
FIGURE 7. Cytotoxicity and cell adhesion studies: (a) cell viability measured after 72 h and (b) cell adhesion on the surface of the different stents.
Biosoft
VR
duo, Porges Stent was used as a control. Statistical significant differences were considered as ***p< 0.001; **p< 0.01; *p< 0.05.
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The biopolymers used in the preparation of the stents
are highly hydrophilic. An inherent characteristic of these
stents is the fact that, in the presence of water, a hydrogel
is formed.35 This behavior is usually coupled with a high
swelling ability, which may disrupt the structure of the matri-
ces. The prepared stents have high water uptake ability,
up to 1000%, after 1 day of immersion (Figure 3). How-
ever, the devices do not present an extensive swelling
behavior as observed by a magnifying lens. Augst et al. refer
that ionic crosslinked alginates dissolve upon losing the
divalent cations responsible for the crosslinking.33 The
observed dissolution rate might also be due to the ionic
change between Ca21 ions by monovalent ions, which
weaken the structure.36 Hydrogels of alginate occurs as a
result of the formation of ionic crosslinks between carboxyl
groups in guluronic acid residues within the polysaccharide.
Each calcium ion is then chelated by two alginate molecules,
forming crosslinks, thus resulting in gelation. When
immersed in distilled water alginate the mechanical proper-
ties will be conserved, however, in the presence of monova-
lent ions (K1 or Na1), in our work in AUS, ion exchange
will occur with the crosslinking Ca21 resulting in a rapid
reduction in mechanical properties.33,36–38
In our experiments, the variation of the ratio of polysac-
charide:gelatin did not show a signiﬁcant effect on the bio-
resorption proﬁle of the samples, although it has been
reported that it may tune the resorption kinetics of hydro-
gels for a wide range of applications and conditions.32,39 In
this perspective, it is possible to design polymeric stents
with the dissolution timeframe that best ﬁts the treatment
strategy (Figure 4). Consequently, the need for a second sur-
gery to remove the stent can be avoided using the proposed
natural-based stents.
The mechanical properties of urinary stents are an
important parameter in order to access the feasibility of the
hydrogel tubes to withstand the forces applied when the
stent is inserted in the patient, assuring that the material
does not break obstructing the ureter and preventing the
ﬂow of urine. Results reported in the literature for a polyur-
ethane double J stents refer an ultimate tensile strength
between 18 and 35 MPa, an elongation at break between
104 and 509% and a Young modulus between 38 and 41
MPa.40 As expected these values are signiﬁcantly higher
than the ones reported in our work for the hydrogels pre-
pared. The tensile properties of the stents produced change
in the presence of gelatin and the results indicate that the
presence of gelatin increases the maximum tensile strain
while decreasing on the other hand the maximum load and
the Young modulus. Few reports in the literature provide
comparable data to the one presented in this work. Nanda-
kumar et al. report the development of hydrophilic high gly-
colic acid–poly(DL-lactic-co-glycolic gcid)/polycaprolactam/
polyvinyl alcohol blends as uretheral materials and tensile
tests carried out refer tensile stresses at maximum load in
the range of 0.66–8.82 MPa, depending on the formula-
tion.41 Nonetheless, the data reported was measured in thin
ﬁlms and not in hollow tubes. Furthermore, there is no indi-
cation that the results were determined in the wet state.
Another work by Jones et al., who evaluated the possibility
to prepare stents from poly(E-caprolactone) and poly(E-ca-
prolactone)-polyvinylpyrrolidone-iodine blends, refer also the
tensile mechanical properties of the ﬁlms prepared which,
disregarding possible geometrical effects, is in the same
order of magnitude of the polyurethane commercial
stents.42 A straightforward comparison of the results should
not, hereafter, be carried out. The alginate and gellan gum-
based stents prepared in this work reveal good mechanical
properties and provide the stability and strength necessary
for manipulation during the placement process and its func-
tion in ureter.
A major concern in urology is the development of
encrustation on urological stents. This phenomenon is
related with the deposition of salts (present in the urine)
on the surface of the stent. When encrustation occurs urine
ﬂow is blocked, causing distress and pain to the patients.
Particularly relevant are magnesium salts in the form of
struvite and or calcium salts in the form of hydroxyapatite.
Alginate and gellan gum stents, as well as the ones prepared
with their mixture with gelatin, were immersed in AUS for
different time periods. In order to study this effect, SEM
micrographs (Figure 5) show a smooth inner surface of the
stents at the initial time points. The micrograph for the last
data point shows some rugosity, which can be explained by
the polymeric dissolution. However these results do not
indicate any evidence of deposited crystals and demonstrate
that no encrustation was developed during the lifetime of
the stent when in contact with AUS. Furthermore, these
observations are consistent with EDS analysis presented in
Figure 5. The EDS spectra clearly indicated the absence of
ions that could suggest struvite or hydroxyapatite formation.
The Ca21 and Cl2 ions detected in the spectra of all poly-
mers are from the crosslinking agent, as they appear only in
the spectra of the materials before immersion and disappear
after immersion in AUS. The hydrophilicity of the tested bio-
polymers can explain these observations, as the high hydra-
tion capacity of hydrogels prevents the deposition of soluble
salts.
Concerning bioﬁlm formation and bacterial adhesion,
reports in the literature suggest that coating commercial
stents with hydrogel may lead to a signiﬁcant decrease in
bacterial adhesion.23,35 In the study of Khandwekar and
Dobel23 commercial stents (TecoﬂexV
R
) were compared to
stents made of polyurethane (TecoﬂexV
R
) modiﬁed vinylpyr-
rolidone–iodine (PVP-I) complex. In their work, the PVP-I
modiﬁed stent was highly hydrophilic and more lubricious
than the control polyurethane. Adherence of both Gram pos-
itive S. aureus (by 1 3 106 CFU/cm2) and Gram-negative
Pseudomonas aeruginosa (by 2 3 106 CFU/cm2) was signiﬁ-
cantly reduced on the modiﬁed surfaces. Our results
obtained for the commercial stent (BiosoftV
R
duo, Porges),
following the same experimental procedure, indicated the
presence of 1.8 3 105 CFU/cm2 for the three tested bacte-
ria’s (S. aureus, E. coli DH5 alpha and K. oxytoca). The mate-
rials tested demonstrated a lower bacterial adherence,
particularly for the Gram-positive bacteria S. aureus,
whereas a reduction of about 312 to 341 of bacterial
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adhesion was observed. For the Gram-negative bacteria, the
tested materials demonstrated a behavior similar to the
commercial stent, although with E. coli DH5 alpha, it was
observed an adhesion reduction of about 32 with two of
the used biomaterials (alginate gelatin and gellan
gum1 gelatin). These results can be explained by the bacte-
rial cell surface structure, since cell-surface hydrophobicity
is an important factor in the adherence and proliferation of
microorganisms on solid surfaces.23,24 Consistently, it was
reported that S. aureus has higher hydrophobicity ability in
comparison with E. coli (cell surface hydrophobicity (CSH)
of E. coli, S. aureus, and Aspergillus niger and the biodegra-
dation of diethyl phthalate (DEP) via microcalorimetry.43,44
Considering the implications of cell surface hydrophobicity
on cell adhesion, our results suggest that including gelatin
on the formulations will be a promising approach in the
reduction of bacterial adhesion as demonstrated by the data
described in Figure 6.
Another crucial concern, in products for medical use and
human consumption, is the evaluation of the cytotoxicity of
the developed materials. Reports in the literature have
described the non-cytotoxicity of the polysaccharides used
in this study, although, it is not straightforward the extrapo-
lation for the developed stents.45 Different processing tech-
niques may inﬂuence the characteristics of the materials
and may induce an undesirable toxic response. The experi-
ments carried out following an ISO27 guideline have shown
that neither the materials nor its leachables are toxic as cell
viability in the experiments with the developed stents is
comparable to the ones in tissue cultured plates. In addi-
tion, ureteral stents should not induce cell adhesion because
they could promote an abnormal cell growth which may
compress the stent, and consequently constrain the normal
urine ﬂow.1 In fact, these materials have been reported for
other tissue engineering applications in which it is possible
to promote cell adhesion.46 It is also well documented that
cells respond to particular morphological and topological
cues.24 Our ﬁndings suggest that the stents prepared did
not induce cell adhesion at the surface. The observed differ-
ences may be related to the processing methodology which
results in a smoother surface, not favorable to cell adhesion.
CONCLUSION
The present work constitutes an important step toward the
development of bioresorbable urological stents. Here, we
described a methodology to prepare stents using natural-
origin polymers templated gelation and drying, using critical
point carbon dioxide, generated stents able to compete with
the commercially available ones. Biopolymers, such as, algi-
nate and gellan gum, as well as their blends with gelatin, pre-
sent different advantages compared to the commercial
products, such as: adequate bioresorption rates; no develop-
ment of encrustation; and anti-bacterial properties. Stents
prepared from alginate present the fastest bioresorption rate,
corresponding to an indwelling time of 21 days. Longer
indwelling periods may be achieved with the use of gellan
gum. The addition of gelatin to the blends decreases the bac-
terial adhesion demonstrating to be a promising strategy to
reduce the bacterial adhesion. Furthermore, the technology
proposed is highly versatile, allowing a wide range of stent
designs. The described stents, when in contact with a physio-
logical medium, become hydrogels, exhibiting biocompatible
and non-cytotoxic characteristics. The presence of a high
equilibrium water content, provides soft, lubricious, and ﬂexi-
ble characteristics to the devices, similar to natural tissue.
The obtained results demonstrate the feasibility to develop
bioresorbable stents from natural origin polysaccharides.
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